Page last updated: 2024-08-24

zolmitriptan and Cancer of Liver

zolmitriptan has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhadauria, AS; Bhattachariya, B; Chakraborti, S; Gosipatala, SB; Kumar R, V; Kumar, D; Kumar, P; Kumar, U; Maity, B; Maurya, V; Pramanik, A; Saha, B; Saha, S; Singh, AK	1

Other Studies

1 other study(ies) available for zolmitriptan and Cancer of Liver

Article	Year
Zolmitriptan attenuates hepatocellular carcinoma via activation of caspase mediated apoptosis. Chemico-biological interactions, 2019, Aug-01, Volume: 308 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cytokines; Disease Models, Animal; Glutathione; Lipids; Liver; Liver Neoplasms; Male; Nitric Oxide Synthase Type II; Oxazolidinones; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Tryptamines	2019

Article

Year

Zolmitriptan attenuates hepatocellular carcinoma via activation of caspase mediated apoptosis.

Chemico-biological interactions, 2019, Aug-01, Volume: 308

Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cytokines; Disease Models, Animal; Glutathione; Lipids; Liver; Liver Neoplasms; Male; Nitric Oxide Synthase Type II; Oxazolidinones; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Tryptamines

2019